1. Academic Validation
  2. Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7

Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7

  • Cell. 2019 Aug 22;178(5):1222-1230.e10. doi: 10.1016/j.cell.2019.07.028.
Kathrin Jaeger 1 Steffen Bruenle 1 Tobias Weinert 1 Wolfgang Guba 2 Jonas Muehle 3 Takuya Miyazaki 4 Martin Weber 2 Antonia Furrer 1 Noemi Haenggi 2 Tim Tetaz 2 Chia-Ying Huang 5 Daniel Mattle 3 Jean-Marie Vonach 2 Alain Gast 2 Andreas Kuglstatter 2 Markus G Rudolph 2 Przemyslaw Nogly 1 Joerg Benz 2 Roger J P Dawson 6 Joerg Standfuss 7
Affiliations

Affiliations

  • 1 Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institute, Villigen PSI.
  • 2 Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland.
  • 3 Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institute, Villigen PSI; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland.
  • 4 Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland; Chugai Pharmaceutical Co., Ltd., Research Division, Kamakura Research Labs, Kamakura, Kanagawa, Japan.
  • 5 Macromolecular Crystallography, Swiss Light Source, Paul Scherrer Institute, 5232 Villigen PSI, Switzerland.
  • 6 Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland. Electronic address: roger.dawson@roche.com.
  • 7 Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institute, Villigen PSI. Electronic address: joerg.standfuss@psi.ch.
Abstract

The CC Chemokine Receptor 7 (CCR7) balances immunity and tolerance by homeostatic trafficking of immune cells. In Cancer, CCR7-mediated trafficking leads to lymph node metastasis, suggesting the receptor as a promising therapeutic target. Here, we present the crystal structure of human CCR7 fused to the protein Sialidase NanA by using data up to 2.1 Å resolution. The structure shows the ligand Cmp2105 bound to an intracellular allosteric binding pocket. A sulfonamide group, characteristic for various Chemokine Receptor ligands, binds to a patch of conserved residues in the Gi protein binding region between transmembrane helix 7 and helix 8. We demonstrate how structural data can be used in combination with a compound repository and automated thermal stability screening to identify and modulate allosteric Chemokine Receptor antagonists. We detect both novel (CS-1 and CS-2) and clinically relevant (CXCR1-CXCR2 phase-II antagonist Navarixin) CCR7 modulators with implications for multi-target strategies against Cancer.

Keywords

CCR7; G protein-coupled receptors; allosteric modulation; cancer; chemokine receptors; crystal structure; lymph node metastasis; membrane proteins; structure-based drug screening.

Figures
Products